Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 03/31/2020 (updated monthly) $1,018.1 (M)
Net Assets - Class C As of 02/29/2020 (updated monthly) $45.6 (M)
P/E Ratio (12-mo Forward)As of 02/29/2020 (updated monthly) 14.97
P/B RatioAs of 02/29/2020 (updated monthly) 5.59

Positions As of 02/29/2020

Portfolio Details

Asset AllocationAs of 03/31/2020

[name] [value]
Equity 92.93%
Cash & Cash Equivalents 7.07%

Geographic BreakdownAs of 03/31/2020

No chart available for this data.
[name] [value]
United States 80.67%
Cash & Cash Equivalents 7.07%
United Kingdom 3.76%
Netherlands 3.03%
Denmark 2.34%
Canada 1.75%
Switzerland 0.69%
Germany 0.60%
Ireland 0.08%

sector breakdownAs of 02/29/2020

[name] [value]
Biotechnology 79.56%
Pharmaceuticals 12.20%
Life Sciences Tools & Services 4.13%
Cash & Cash Equivalents 4.11%

TOP TEN HOLDINGSAs of 03/31/2020

51.79%
Other
0% 100%
[holdings-table-heading]
VERTEX PHARMACEUTICALS INC 7.94%
BIOGEN INC 6.77%
AMGEN INC 6.35%
GILEAD SCIENCES INC 6.30%
REGENERON PHARMACEUTICALS INC 6.14%
ILLUMINA INC 4.72%
IOVANCE BIOTHERAPEUTICS INC 4.17%
GW PHARMACEUTICALS PLC 3.63%
PTC THERAPEUTICS INC 3.30%
REATA PHARMACEUTICALS INC 2.47%